- Conditions
- Panic Disorder
- Interventions
- Darigabat, Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 31
- States / cities
- Phoenix, Arizona • Lafayette, California • Los Angeles, California + 27 more
Source: ClinicalTrials.gov public record
Updated May 6, 2026 · Synced May 21, 2026, 9:50 PM EDT